Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway

Cell Death and Disease

Volumn 5, Issue 8, 2014, Pages

  Jiao, M ^a,b   Ren, F ^b   Zhou, L ^b   Zhang, X ^b   Zhang, L ^a   Wen, T ^b   Wei, L ^b   Wang, X ^b   Shi, H ^b   Bai, L ^b   Zheng, S ^b   Zhang, J ^b   Chen, Y ^b   Han, Y ^c   Zhao, C ^a   Duan, Z ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; BECLIN 1; CCL1 CHEMOKINE; CELL PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PROTEIN P62; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE; ATG7 PROTEIN, MOUSE; CHEMOKINE; CYTOKINE; GALACTOSAMINE; LIPOPOLYSACCHARIDE; MICROTUBULE ASSOCIATED PROTEIN; PROTECTIVE AGENT; PYRIMIDINE DERIVATIVE; TLR4 PROTEIN, MOUSE;

ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPHAGY; CELL PROTECTION; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL DAMAGE; LIVER PROTECTION; MACROPHAGE CULTURE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACUTE DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HEPATITIS B; INFLAMMATION; LIVER FAILURE; MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE;

ACUTE DISEASE; ADENINE; ADULT; ANIMALS; AUTOPHAGY; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GALACTOSAMINE; HEPATITIS B; HEPATOCYTES; HUMANS; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; LIVER FAILURE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PHOSPHORYLATION; PPAR ALPHA; PROTECTIVE AGENTS; PYRIMIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84906860217     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.361     Document Type: Article

References (49)

1. Hoofnagle JH, Carithers RJ, Shapiro C, Ascher N. Acute hepatic failure: summary of a workshop. Hepatology 1995; 21: 240-252.
2. Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003; 23: 203-215.
3. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-688.
4. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51: 85-94.
5. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998; 98: 2088-2093.
6. Chinetti G, Griglio S, Antonucci M, Pineda TI, Delerive P, Majd Z et al. Activation of peroxisome proliferator activated receptors α and γ induces apoptosis of human monocyte derived macrophages. J Biol Chem 1998; 273: 25573-25580.
7. Delerive P, De BK, Besnard S, Vanden BW, Peters JM, Gonzalez FJ et al. PPARα negatively regulates the vascular inflammatory gene response by negative cross talk with transcription factors NF-κB and AP-1. J Biol Chem 1999; 274: 32048-32054.
8. Devchand PR, Keller H, Peters JM, Vasquez M, Gonzalez FJ, Wahli W. The PPARα-leukotriene B pathway to inflammation control. Nature 1996; 384: 39-43.
9. Staels B, Koenig W, Habib A, Merval R, Lebret M, Pineda-Torra I et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 1998; 393: 790-793.
10. Lee JH, Joe EH, Jou I. PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. NeuroReport 2005; 16: 829-833.
11. Delayre OC, Becker J, Guenon I, Lagente V, Auwerx J, Frossard N et al. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res 2005; 6: 91-100.
12. Di PR, Esposito E, Mazzon E, Genovese T, Muia C, Crisafulli C et al. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. Shock 2006; 26: 477-484.
13. Sheu MY, Fowler AJ, Kao J, Schmuth M, Schoonjans K, Auwerx J et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118: 94-101.
14. Seong HY, Mohamed AA, Byoung JS. Activation of PPARa by Wy-14,643 ameliorates systemic lipopolysaccharide-induced acute lung injury. Biochem Biophys Res Commun 2013; 9: 0006-291X(13)00870-X.
15. Stephen WS, Charles CC, Basilia Z, Hector RW. Reduced peroxisome proliferator-activated receptor a expression is associated with decreased survival and increased tissue bacterial load in sepsis. Shock 2012; 37: 164-169.
16. Seong HY, Ogyi P, Lauren EH, Mohamed AA, Kwan HM, Byoung JS. Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress. Toxicol Lett 2011; 202: 23-29.
17. Mignon A, Rouquet N, Fabre M, Martin S, Pagès JC, Dhainaut JF et al. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 1999; 159: 1308-1315.
18. Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T et al. Etoposide prevents apoptosis inmouse liver with D-GalN/LPS-induced fulminant hepatic failure resulting inreduction of lethality. Hepatology 2001; 33: 1441-1450.
19. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2: 211-216.
20. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
21. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007; 7: 767-777.
22. Beth L, Noboru M, Herbert WV. Autophagy in immunity and inflammation. Nature 2011; 469: 323-335.
23. Alexander JSC, Stefan WR. Autophagy in inflammatory diseases. Int J Cell Biol 2011; 2011: 732798.
24. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J 2008; 27: 1110-1121.
25. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27: 135-144.
26. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T et al. loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 2008; 456: 264-268.
27. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222-230.
28. Gyongyi S, Pranoti M. Angela D. Innate immune response and hepatic inflammation. Semin Liver Dis 2007; 27: 339-350.
29. Jie Z, Zh Wei, Bing L, Mathew CC, Diana WM, Min W et al. PPARγ activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol 2009; 41: 2334-2342.
30. Delayre OC, Becker J, Guenon I, Lagente V, Auwerx J, Frossard N et al. PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res 2005; 6: 91-100.
31. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K et al. Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage. Hepatology 2004; 40: 972-980.
32. Nan YM, Kong LB, Ren WG, Wang RQ, Du JH, Li WC et al. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. Lipids Health Dis 2013; 12: 11-20.
33. Seong HY, Ogyi P, Lauren EH, Mohamed AA, Kwan HM, Byoung JS. Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress. Toxicol Lett 2011; 202: 23-29.
34. Emilia I, Geoff F, Pauline H, Graham R, Isabelle L. Administration of the potent PPARα Agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 2004; 39: 1286-1296.
35. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-739.
36. Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 2004; 41: 613-620.
37. Su GL. Lipopolysaccharides in liver injury: molicular mechanisms of kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002; 283: G256-G265.
38. Matsuno K, Nomiyama H, Yoneyama H, Uwatoku R. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002; 9: 143-149.
39. Klugewitz K, Adams DH, Emoto M, Eulenburg K, Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol 2004; 25: 590-594.
40. Bertus E, Simon CA, Stephen JW, Andrew PH, David HA. Immune-mediated liver injury. Semin Liver Dis 2007; 27: 351-366.
41. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol 1999; 66: 10-24.
42. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544.
43. Fésüs L, Demény MÁ, Petrovski G. Autophagy shapes inflammation. Antioxid Redox Signal 2011; 14: 2233-2243.
44. Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P et al. MicroRNA-141 represses HBV replication by targeting PPARa. PLoS One 2012; 7: e34165.
45. Wu YT, Tan HL, Huang Q, Ong CN, Shen HM. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy 2009; 5: 824-834.
46. Sovan S, Janet ED, Marie F, Moises GA, Zeyn GT, Maria JS et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90: 1383-1435.
47. Liyan C, Feng R, Haiyan Z, Tao W, Zhengfu P, Li Z et al. Inhibition of GSK3b ameliorates D-GalN/LPS-induced liver injury by reducing ERS-triggered apoptosis. PLoS One 2012; 7: e45202.
48. Feng R, Zhongping D, Xiuda S, Shen X, Gao F, Bai L et al. The inhibition of GSK3b ameliorates liver ischemia reperfusion injury via an IL-10-mediated immune modulatory mechanism. Hepatology 2011; 54: 687-696.
49. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 1981; 17: 913-925.